Investigators in the Division of Pulmonary, Allergy and Critical Care Medicine have made a monumental discovery regarding idiopathic pulmonary Thannickalfibrosis, an often fatal lung disease with no cure and no effective treatments. In findings published March 1, 2013, in the Journal of Clinical Investigation, the research team has discovered a new pathway that contributes to fibrosis, or scarring in the lungs. More importantly, they may have also found a potential treatment to block that pathway.

To read more, go to: http://www.uab.edu/news/latest/item/3282-uab-researchers-discover-possible-treatment-for-incurable-lung-disease

 

UAB ECMO Program Achieves "Gold Level" Rating
Extracorporeal Life Support Organization recognizes UAB as a Center of Excellence
First in U.S. Comprehensive Dialysis Visit Via Telemedicine
Eric Wallace, MD, assesses home dialysis patient from 90 miles away
Department Sweeps 2016 SOM Dean's Excellence Awards
L to R: Blalock, Elopre, Pollock, Massie, Kennedy
Good News Update
Jeff Foster Selected DOM Employee of the Year

Medical Grand Rounds Calendar

Research Spotlight Cynthia Brown MD
EOM Header Estrada
Ask the Chair of the Department of Medicine